NEW YORK (GenomeWeb News) — PerkinElmer today said its neonatal screening technology will help expand a screening program in The Netherlands.
 
The company said it will provide four tandem mass spec systems, reagents, and software to support the nation’s five hospital screening centers.
 
The partnership will enable the country to screen for 14 disorders compared with three disorders.
Financial terms of the alliance were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.